{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T11:29:17Z","timestamp":1750937357184},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00120-020-01358-8","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T09:02:58Z","timestamp":1602493378000},"page":"1492-1497","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Der Urologe als Impfarzt"],"prefix":"10.1007","volume":"59","author":[{"given":"P.","family":"Schneede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. B.","family":"Schneede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"1358_CR1","unstructured":"Betsch C, von Hirschhausen E, Zylka-Menhorn V (2019) Professionelle Gespr\u00e4chsf\u00fchrung \u2013 wenn Reden Gold wert ist. Dtsch Arztebl 116: B\u2011427\u2013433"},{"key":"1358_CR2","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00120-018-0807-z","volume":"57","author":"W B\u00fchmann","year":"2018","unstructured":"B\u00fchmann\u00a0W (2018) Impfen: Schutz f\u00fcr Jungen vor Genitalwarzen und Krebs durch Humane-Papillomviren-Infektion. Urologe 57:1499\u20131508","journal-title":"Urologe"},{"key":"1358_CR3","first-page":"A7","volume":"95","author":"J B\u00fctikofer","year":"1998","unstructured":"B\u00fctikofer J (1998) Schlu\u00dfwort Dtsch Arztebl 95:A7","journal-title":"Dtsch Arztebl"},{"key":"1358_CR4","unstructured":"Be (2002) Rechtsreport. Pflicht zur Fortbildung. Impferlaubnis darf an Nachweis gekoppelt werden. Dtsch Arztebl 99: A2504"},{"key":"1358_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.0016","author":"AF Dempsey","year":"2018","unstructured":"Dempsey AF, Pyrznawoski J, Lockhart S et\u00a0al (2018) Effect of a\u00a0Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination. A Cluster Randomized Clinical Trial. JAMA Pediatr. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.0016","journal-title":"JAMA Pediatr"},{"key":"1358_CR6","unstructured":"(2020) Empfehlungen der St\u00e4ndigen Impfkommission beim Robert Koch-Institut \u2013 2019. Epid Bull 34:313\u2013364"},{"key":"1358_CR7","unstructured":"(2005) emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). https:\/\/www.who.int\/news-room\/detail\/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-. Zugegriffen: 20. Juni 2020"},{"key":"1358_CR8","unstructured":"https:\/\/www.gesetze-im-internet.de\/ifsg\/IfSG.pdf. Zugegriffen: 20. Juni 2020"},{"key":"1358_CR9","unstructured":"https:\/\/www.blaek.de\/kammerrecht\/weiterbildungsordnung\/. Zugegriffen: 20. Juni 2020"},{"key":"1358_CR10","unstructured":"https:\/\/ipvsoc.org\/hpv-day\/. Zugegriffen: 20. Juni 2020"},{"key":"1358_CR11","unstructured":"https:\/\/medizin-aspekte.de\/urologen-empfehlen-die-hpv-impfung-fuer-jungen-65203. Zugegriffen: 20. Juni 2020"},{"key":"1358_CR12","unstructured":"https:\/\/www.rki.de\/DE\/Content\/Kommissionen\/STIKO\/Empfehlungen\/Aktuelles\/Impfkalender.pdf?_blob=publicationFile. Zugegriffen: 20. Juni 2020"},{"key":"1358_CR13","unstructured":"https:\/\/www.who.int\/emergencies\/ten-threats-to-global-health-in-2019. Zugegriffen: 2. Apr. 2019"},{"key":"1358_CR14","first-page":"A1382","volume":"115","author":"SJ Klug","year":"2018","unstructured":"Klug\u00a0SJ, Meerpohl\u00a0J, R\u00f6bl-Mathieu\u00a0M et al (2018) HPV-Impfung. Auch Jungen K\u00f6nnen Profitieren Dtsch \u00c4rzteblatt 115:A1382\u20131386","journal-title":"Auch Jungen K\u00f6nnen Profitieren Dtsch \u00c4rzteblatt"},{"key":"1358_CR15","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1007\/s00120-018-0793-1","volume":"57","author":"SJ Klug","year":"2018","unstructured":"Klug\u00a0SJ, van der Sande\u00a0M, Terhardt\u00a0M et al (2018) Die STIKO empfiehlt die HPV-Impfung jetzt auch f\u00fcr Jungen. Urologe 57:1346\u20131350","journal-title":"Urologe"},{"key":"1358_CR16","unstructured":"Pers\u00f6nliche Kongressaufzeichnung: Reuschenbach M, W\u00f6lle R, Mihm S, et\u00a0al. (2019) HPV vaccination uptake in boys after introduction of gender-neutral HPV vaccination in Germany\u2014A retrospective database analysis (IMS Vaccine Analyzer). Vorgestellt auf dem EUROGIN-Kongress, 04. bis 07. Dezember 2019, Monaco"},{"key":"1358_CR17","unstructured":"Pers\u00f6nliche Rechtsauskunft: Nachtigall N, Referat Weiterbildung II, Bayerische Landes\u00e4rztekammer, M\u00fcnchen, Schreiben vom 29. Mai 2020"},{"key":"1358_CR18","first-page":"141","volume":"e20170498","author":"CM Rand","year":"2018","unstructured":"Rand CM, Schaffer SJ, Dhepyasuwan N et\u00a0al (2018) Provider communication, prompts, and feedback to improve HPV vaccination rates in resident clinics. Pediatr Electron Pages 141:e20170498","journal-title":"Electron"},{"key":"1358_CR19","first-page":"A2379","volume":"104","author":"S Rieser","year":"2007","unstructured":"Rieser\u00a0S (2007) Richtlinie Schutzimpfungen \u2013 Einschr\u00e4nkung f\u00fcr Fach\u00e4rzte. Dtsch Arztebl 104:A2379\u20132380","journal-title":"Dtsch Arztebl"},{"key":"1358_CR20","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1007\/s00120-006-1232-2","volume":"45","author":"P Schneede","year":"2006","unstructured":"Schneede\u00a0P, Schlenker\u00a0B, Hungerhuber\u00a0E (2006) Condylomata acuminata. Eine Indikation f\u00fcr HPV-Vakzination? Urologe 45:1514\u20131520","journal-title":"Urologe"},{"key":"1358_CR21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00120-017-0394-4","volume":"56","author":"P Schneede","year":"2017","unstructured":"Schneede\u00a0P (2017) Ein Jahrzehnt der HPV-Impfung in Deutschland. Urologe 56:728\u2013733","journal-title":"Urologe"},{"key":"1358_CR22","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1007\/s00120-018-0770-8","volume":"57","author":"P Schneede","year":"2018","unstructured":"Schneede\u00a0P (2018) Krankheitslast humaner Papillomviren der M\u00e4nner. HPV-Vorsorge wird M\u00e4nnersache. Urologe 57:1452\u20131456","journal-title":"Urologe"},{"key":"1358_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00120-018-0597-3","volume":"57","author":"P Schneede","year":"2018","unstructured":"Schneede\u00a0P, Schlenker\u00a0B (2018) Humane Papillomviren und Peniskarzinom. \u00dcberlegungen zu Pr\u00e4ventionsma\u00dfnahmen. Urologe 57:413\u2013417","journal-title":"Urologe"},{"key":"1358_CR24","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00120-019-01055-1","volume":"58","author":"P Schneede","year":"2019","unstructured":"Schneede\u00a0P (2019) Verbesserung der Impft\u00e4tigkeiten in der Urologie. Urologe 58:1353\u20131360","journal-title":"Urologe"},{"key":"1358_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/infdis\/jiu370","volume":"211","author":"MA Smith","year":"2015","unstructured":"Smith\u00a0MA, Lin\u00a0B, McIntyre\u00a0P et\u00a0al (2015) Fall in genital warts diagnoses in the general and indigenons Austalian population following implementation of a\u00a0national human papillomavirus vaccination programm: analysis of routinely collected national hospital data. J\u00a0Infect Dis 211:91\u201399","journal-title":"J Infect Dis"},{"key":"1358_CR26","first-page":"233","volume":"26","author":"STIKO (St\u00e4ndige Impfkommission am Robert Koch-Institut)","year":"2018","unstructured":"STIKO (St\u00e4ndige Impfkommission am Robert Koch-Institut) (2018) Wissenschaftliche Begr\u00fcndung der HPV-Impfung f\u00fcr Jungen im Alter von 9 bis 14\u00a0Jahren. Epidemiol Bull 26:233\u2013250","journal-title":"Epidemiol Bull"},{"key":"1358_CR27","first-page":"20180303","volume":"B374","author":"A Willemsen","year":"2019","unstructured":"Willemsen\u00a0A, Bravo\u00a0IG (2019) Origin and evolution of papillomavirus (onco)genes and genomes. Phil Trans R. Soc B374:20180303","journal-title":"Soc"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-020-01358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-020-01358-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-020-01358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T07:41:38Z","timestamp":1634024498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-020-01358-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1358"],"URL":"https:\/\/doi.org\/10.1007\/s00120-020-01358-8","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"12 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Schneede: Finanzielle Interessen: Als eingeladener Referent verschiedener Fort- und Weiterbildungsveranstaltungen wurden entweder Reise- und \u00dcbernachtungskosten erstattet oder zus\u00e4tzlich \u00fcbliche Honorare in H\u00f6he von 500\u20131000\u202f\u20ac von den Kongressveranstaltern gezahlt. S\u00e4mtliche Honorare gingen auf ein von der Klinikumverwaltung des Klinikums Memmingen gef\u00fchrtes Drittmittelkonto. Da Kongressveranstalter in der Regel wechseln, wurde lediglich von der Paul-Ehrlich-Gesellschaft (PEG) als Kongressveranstalter des HPV-Management-Forums, einer AG der PEG, regelm\u00e4\u00dfig f\u00fcr j\u00e4hrliche Fort- und Weiterbildungen ein Honorar in H\u00f6he von 500\u202f\u20ac neben Reisekosten erstattet. Insgesamt wurden Honorare unter 10.000\u202f\u20ac in den letzten 5\u00a0Jahren eingenommen. Honorierungen von Industrie oder Wirtschaft in direktem Vertragsverh\u00e4ltnis wurden stets abgelehnt. Nichtfinanzielle Interessen: Chefarzt der Urologie des Klinikums Memmingen, 87700 Memmingen, Bismarckstra\u00dfe\u00a023 |\u00a0Lehrbeauftragter des Lehrkrankenhauses der LMU M\u00fcnchen |\u00a0Leiter des DKG-zertifizierten Prostatakarzinomzentrums sowie des zertifizierten Laserzentrums am Klinikum Memmingen |\u00a0Mitgliedschaften: DGU, EAU, PEG-HPV-MF, DSTIG. J.\u00a0B.\u00a0Schneede gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}